Background Antipsychotic treatment is associated with metabolic disturbance. However, the
degree to which metabolic alterations occur in treatment with different antipsychotics is …

Originally published in February 2004. This guideline is more than 5 years old and has not
yet been updated to ensure that it reflects current knowledge and practice. In accordance …

OBJECTIVE: The purpose of this study was to estimate and compare the effects of
antipsychotics—both the newer ones and the conventional ones—on body weight …

OBJECTIVE: The goal of this 5-year naturalistic study of patients treated with clozapine was
to examine the incidence of treatment-emergent diabetes mellitus in relation to other factors …

With the availability of the so-called novel antipsychotic agents, extrapyramidal symptoms
are becoming decreasingly problematic for patients with schizophrenia, and simultaneously …

Objectives: The purpose of this paper is to review the literature since 1970 documenting the
effects of antipsychotic agents on serum lipids, including a discussion of possible …

Background: We performed a retrospective analysis of 122 clinical records of 92 male
patients with DSM-III-R schizophrenia to examine the relative weight gain liabilities of …

Almost fifty years after its first introduction into clinical care, clozapine remains the only
evidence-based pharmacological option for treatment-resistant schizophrenia (TRS), which …

Baptista T. Body weight gain induced by antipsychotic drugs: mechanisms and
management. Acta Psychiatrica Scand 1999: 100: 3–16.© Munksgaard 1999. Long‐term …

Background: Childhood-onset schizophrenia is a rare but severe form of the disorder that is
often treatmentrefractory. In this study, the efficacy and adverse effects of clozapine and …